HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Kawaguchi Selected Research

Viral Matrix Proteins

1/2022ARHGAP1 Transported with Influenza Viral Genome Ensures Integrity of Viral Particle Surface through Efficient Budozone Formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Kawaguchi Research Topics

Disease

27Neoplasms (Cancer)
11/2021 - 03/2003
12Inflammation (Inflammations)
07/2022 - 09/2003
10Hepatocellular Carcinoma (Hepatoma)
11/2021 - 11/2011
9Infections
07/2022 - 12/2004
8Human Influenza (Influenza)
01/2022 - 08/2008
6Fibrosis (Cirrhosis)
01/2022 - 06/2014
6Glioma (Gliomas)
01/2020 - 03/2012
6Colitis
09/2013 - 04/2005
5COVID-19
01/2022 - 07/2020
5Non-alcoholic Fatty Liver Disease
01/2022 - 01/2014
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2014 - 01/2004
4Hemorrhage
05/2022 - 08/2013
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2017
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2020 - 01/2018
4Lung Neoplasms (Lung Cancer)
01/2020 - 04/2015
4Lymphoma (Lymphomas)
01/2020 - 10/2012
4Liver Cirrhosis (Hepatic Cirrhosis)
07/2019 - 05/2011
4Hypertension (High Blood Pressure)
12/2018 - 01/2017
3Respiratory Insufficiency (Respiratory Failure)
01/2022 - 02/2013
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 01/2012
3Septic Shock (Toxic Shock Syndrome)
08/2021 - 01/2020
3Sepsis (Septicemia)
08/2021 - 06/2020
3Insulin Resistance
01/2021 - 01/2015
3Neoplasm Metastasis (Metastasis)
01/2021 - 02/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2018
3Asthma (Bronchial Asthma)
01/2021 - 01/2017
3Critical Illness (Critically Ill)
01/2020 - 09/2018
3Glioblastoma (Glioblastoma Multiforme)
10/2019 - 04/2018
3Stomach Neoplasms (Stomach Cancer)
02/2019 - 03/2003
3Breast Neoplasms (Breast Cancer)
02/2019 - 10/2012
3Ulcerative Colitis
08/2013 - 03/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 11/2019
2Myocardial Infarction
01/2022 - 12/2021
2Vomiting
08/2021 - 07/2020
2Wounds and Injuries (Trauma)
01/2021 - 06/2016
2Hypoxia (Hypoxemia)
07/2020 - 06/2012
2Neurobehavioral Manifestations
01/2020 - 01/2019
2Ventilator-Associated Pneumonia
01/2020 - 01/2012
2Treatment-Resistant Depressive Disorder
01/2020 - 01/2019
2Carcinogenesis
07/2019 - 01/2015
2Acne Vulgaris
01/2019 - 01/2010
2Adenocarcinoma of Lung
10/2018 - 01/2016
2Atopic Dermatitis (Atopic Eczema)
01/2018 - 01/2017
2Lung Diseases (Lung Disease)
01/2017 - 02/2013
2Atrophy
01/2017 - 06/2014
2Virus Diseases (Viral Diseases)
01/2016 - 01/2015
2Disease Progression
12/2015 - 06/2014

Drug/Important Bio-Agent (IBA)

11Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
9CytokinesIBA
01/2022 - 09/2003
9Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2011
6Serum AlbuminIBA
01/2022 - 08/2014
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2014
5PeriostinIBA
11/2019 - 05/2011
4Tyrosine Kinase InhibitorsIBA
07/2020 - 01/2018
4RNA (Ribonucleic Acid)IBA
10/2019 - 09/2013
4Biological ProductsIBA
01/2019 - 03/2011
4Messenger RNA (mRNA)IBA
09/2013 - 12/2009
3InterleukinsIBA
07/2022 - 09/2019
3AlbuminsIBA
01/2022 - 11/2014
3RibonucleoproteinsIBA
01/2022 - 01/2016
3Insulin (Novolin)FDA Link
01/2022 - 01/2015
3Pioglitazone (Actos)FDA Link
01/2022 - 01/2015
3BilirubinIBA
07/2019 - 06/2014
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2012
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2017 - 03/2003
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
05/2013 - 03/2011
3Dextrans (Dextran)FDA Link
05/2013 - 03/2011
3AntibodiesIBA
04/2012 - 10/2009
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 12/2020
2PlatinumIBA
01/2022 - 12/2015
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2015
2Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2017
2EnzymesIBA
11/2021 - 03/2011
2Sorafenib (BAY 43-9006)FDA Link
11/2021 - 02/2021
2Tiotropium Bromide (Spiriva)FDA Link
01/2021 - 01/2020
2InflammasomesIBA
01/2021 - 10/2019
2tiotropium-olodaterolIBA
01/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2020 - 10/2018
2Pharmaceutical PreparationsIBA
11/2019 - 11/2005
2Interleukin-4 (Interleukin 4)IBA
11/2019 - 04/2018
2IronIBA
07/2019 - 01/2012
2Uric Acid (Urate)IBA
12/2018 - 01/2017
2Glycoproteins (Glycoprotein)IBA
02/2018 - 12/2004
2Therapeutic UsesIBA
02/2018 - 06/2012
2Antihypertensive Agents (Antihypertensives)IBA
10/2017 - 02/2013
2Oxygen (Dioxygen)IBA
10/2017 - 12/2016
2DNA-Directed RNA Polymerases (RNA Polymerase)IBA
10/2015 - 08/2008
2CholesterolIBA
01/2015 - 01/2014
2Amino AcidsFDA Link
06/2014 - 01/2013

Therapy/Procedure

16Therapeutics
01/2021 - 11/2005
10Drug Therapy (Chemotherapy)
01/2022 - 06/2012
4Critical Care (Surgical Intensive Care)
08/2021 - 09/2020
4Immunotherapy
01/2019 - 11/2005
3Artificial Respiration (Mechanical Ventilation)
01/2022 - 10/2017
3Radiotherapy
11/2019 - 04/2015
3Lasers (Laser)
06/2016 - 08/2008
2Renal Dialysis (Hemodialysis)
11/2021 - 01/2016
2Noninvasive Ventilation
07/2020 - 10/2017
2Transcranial Magnetic Stimulation
01/2020 - 01/2019